Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oramed Pharmaceuticals (ORMP) Total Non-Current Liabilities (2022 - 2025)

Oramed Pharmaceuticals' Total Non-Current Liabilities history spans 4 years, with the latest figure at $12.0 million for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities changed N/A year-over-year to $12.0 million; the TTM value through Dec 2025 reached $12.0 million, changed N/A, while the annual FY2025 figure was $12.0 million, N/A changed from the prior year.
  • Total Non-Current Liabilities reached $12.0 million in Q4 2025 per ORMP's latest filing, roughly flat from $12.0 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $12.0 million in Q3 2025 to a low of $2.2 million in Q1 2025.
  • Average Total Non-Current Liabilities over 4 years is $5.2 million, with a median of $4.4 million recorded in 2023.
  • The largest YoY upside for Total Non-Current Liabilities was 181.01% in 2025 against a maximum downside of 50.79% in 2025.
  • A 4-year view of Total Non-Current Liabilities shows it stood at $4.7 million in 2022, then dropped by 6.24% to $4.4 million in 2023, then fell by 3.56% to $4.3 million in 2024, then surged by 180.77% to $12.0 million in 2025.
  • Per Business Quant, the three most recent readings for ORMP's Total Non-Current Liabilities are $12.0 million (Q4 2025), $12.0 million (Q3 2025), and $4.4 million (Q2 2025).